trial · primary record
R-DXd
Solid Cancer
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 860 |
| Primary completion | 2030-04-30 |
| Primary endpoint | Objective Response Rate (ORR) Based on Blinded Independent Central Review (BICR) Assessment (Part A) |
| Registry ID | NCT06161025 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:05.657Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06161025
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.